Olav Engebråten

Associate Professor - Institute for Cancer Research
Image of Olav Engebråten
Norwegian version of this page
Username
Visiting address OUS Radiumhospitalet Ullernchausseen 70 0372 Oslo
Postal address OUS, Rikshospitalet Postboks 4950 Nydalen 0424 Oslo

Publications

  • Gythfeldt, Hedda von der Lippe; Lien, Tonje Gulbrandsen; Tekpli, Xavier; Silwal-Pandit, Laxmi; Borgen, Elin; Garred, Øystein; Skjerven, Helle; Schlichting, Ellen; Lundgren, Steinar; Wist, Erik; Naume, Bjørn; Kristensen, Vessela N.; Børresen-Dale, Anne-Lise; Lingjærde, Ole Christian & Engebråten, Olav (2020). Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer. International Journal of Cancer.  ISSN 0020-7136.  147(9), s 2515- 2525 . doi: 10.1002/ijc.33108 Full text in Research Archive.
  • Pladsen, Arne Valebjørg; Nilsen, Gro; Rueda, Oscar M.; Aure, Miriam Ragle; Borgan, Ørnulf; Liestøl, Knut; Vitelli, Valeria; Frigessi Di Rattalma, Arnoldo; Langerød, Anita; Mathelier, Anthony; Engebråten, Olav; Kristensen, Vessela N.; Wedge, David C.; Van Loo, Peter; Caldas, Carlos; Børresen-Dale, Anne-Lise; Russnes, Hege Elisabeth Giercksky & Lingjærde, Ole Christian (2020). DNA copy number motifs are strong and independent predictors of survival in breast cancer. Communications Biology.  ISSN 2399-3642.  3 . doi: 10.1038/s42003-020-0884-6 Full text in Research Archive.
  • Andersson, Yvonne; Inderberg, Else Marit; Kvalheim, Gunnar; Herud, Morten Theodor Malmer; Engebråten, Olav; Flatmark, Kjersti; Dueland, Svein & Fodstad, Øystein (2019). Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients. Acta Oncologica.  ISSN 0284-186X.  s 1- 7 . doi: 10.1080/0284186X.2019.1704864
  • Debik, Julia Barbara; Euceda, Leslie R.; Lundgren, Steinar; Gythfeldt, Hedda; Garred, Øystein; Borgen, Elin; Engebråten, Olav; Bathen, Tone Frost & Giskeødegård, Guro F. (2019). Assessing treatment response and prognosis by serum and tissue metabolomics in breast cancer patients. Journal of Proteome Research.  ISSN 1535-3893.  18(10), s 3649- 3660 . doi: 10.1021/acs.jproteome.9b00316 Full text in Research Archive.
  • Lai, Xiaoran; Geier, Oliver; Fleischer, Thomas; Garred, Øystein; Borgen, Elin; Funke, Simon Wolfgang; Kumar, Surendra; Rognes, Marie Elisabeth; Seierstad, Therese; Børresen-Dale, Anne-Lise; Kristensen, Vessela N.; Engebråten, Olav; Kohn Luque, Alvaro & Frigessi Di Rattalma, Arnoldo (2019). Towards personalized computer simulation of breast cancer treatment: a multi-scale pharmacokinetic and pharmacodynamic model informed by multi-type patient data. Cancer Research.  ISSN 0008-5472.  79(16), s 4293- 4304 . doi: 10.1158/0008-5472.CAN-18-1804 Full text in Research Archive.
  • Lindholm, Evita Maria; Aure, Miriam Ragle; Haugen, Mads Haugland; Sahlberg, Kristine Kleivi; Kristensen, Vessela N.; Nebdal, Daniel J.H.; Børresen-Dale, Anne-Lise; Lingjærde, Ole Christian & Engebråten, Olav (2019). miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer. Molecular Oncology.  ISSN 1574-7891.  13(10), s 2278- 2296 . doi: 10.1002/1878-0261.12561 Full text in Research Archive.
  • Nome, Marianne Eikhom; Euceda, Leslie R.; Jabeen, Shakila; Debik, Julia; Bathen, Tone Frost; Giskeødegård, Guro F.; Tasken, Kristin Austlid; Mælandsmo, Gunhild Mari; Halvorsen, Bente; Yndestad, Arne; Borgen, Elin; Garred, Øystein; Aukrust, Pål; Ueland, Thor; Engebråten, Olav; Kristensen, Vessela N. & Tekpli, Xavier (2019). Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers. International Journal of Cancer.  ISSN 0020-7136.  146(1), s 223- 235 . doi: 10.1002/ijc.32638 Full text in Research Archive.
  • Bidard, François-Clément; Michiels, Stefan; Riethdorf, Sabine; Mueller, Volkmar; Esserman, Laura J.; Lucci, Anthony; Naume, Bjørn; Horiguchi, Jun; Gisbert-Criado, Rafael; Sleijfer, Stefan; Toi, Masakazu; García-Sáenz, José A.; Hartkopf, Andreas; Generali, Daniele; Rothé, Françoise; Smerage, Jeffrey; Muinelo-Romay, Laura; Stebbing, Justin; Viens, Patrice; Magbanua, Mark Jesus M.; Hall, Carolyn S.; Engebråten, Olav; Takata, Daisuke; Vidal-Martínez, José; Onstenk, Wendy; Fujisawa, Noriyoshi; Diaz-Rubio, Eduardo; Taran, Florin-Andrei; Cappelletti, Maria Rosa; Ignatiadis, Michail; Proudhon, Charlotte; Wolf, Denise M.; Bauldry, Jessica B.; Borgen, Elin; Nagaoka, Rin; Caranana, Vicente; Kraan, Jaco; Maestro, Marisa; Brucker, Sara Yvonne; Weber, Karsten; Reyal, Fabien; Amara, Dominic; Karhade, Mandar G.; Ruud, Randi Margit; Tokiniwa, Hideaki; Llombart-Cussac, Antonio; Meddis, Alessandra; Blanche, Paul; D'Hollander, Koenraad & Pantel, Klaus (2018). Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A Meta-analysis. Journal of the National Cancer Institute.  ISSN 0027-8874.  110(6), s 560- 567 . doi: 10.1093/jnci/djy018
  • Fusser, Markus; Øverbye, Anders; Pandya, Abhilash D.; Mørch, Ýrr Asbjørg; Borgos, Sven Even F.; Kildal, Wanja; Snipstad, Sofie; Sulheim, Einar; Fleten, Karianne Giller; Askautrud, Hanne Arenberg; Engebråten, Olav; Flatmark, Kjersti; Iversen, Tore Geir; Sandvig, Kirsten; Skotland, Tore & Mælandsmo, Gunhild Mari (2018). Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft. Journal of Controlled Release.  ISSN 0168-3659.  293, s 183- 192 . doi: 10.1016/j.jconrel.2018.11.029 Full text in Research Archive.
  • Jabeen, Shakila; Zucknick, Manuela; Nome, Marianne Eikhom; dannenfelser, ruth; Fleischer, Thomas; Kumar, Surendra; Luders, Torben; Gythfeldt, Hedda; Troyanskaya, Olga; Kyte, Jon A; Børresen-Dale, Anne-Lise; Naume, Bjørn; Tekpli, Xavier; Engebråten, Olav & Kristensen, Vessela N. (2018). Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab. Oncoimmunology.  ISSN 2162-4011.  7(11), s e1457598-1- e1457598-15 . doi: 10.1080/2162402X.2018.1457598
  • Møller, Elen Kristine; Nord, Silje; Wedge, David C; Lingjærde, Ole Christian; Silwal-Pandit, Laxmi; Gythfeldt, Hedda; Vollan, Hans Kristian Moen; Fleischer, Thomas; Krohn, Marit; Schlichting, Ellen; Borgen, Elin; Garred, Øystein; Holmen, Marit Muri; Wist, Erik; Naume, Bjørn; Van Loo, Peter; Børresen-Dale, Anne-Lise; Engebråten, Olav & Kristensen, Vessela N. (2018). Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Genome Medicine.  ISSN 1756-994X.  10:92 . doi: 10.1186/s13073-018-0601-y Full text in Research Archive.
  • Prasmickaite, Lina; Tenstad, Ellen; Pettersen, Solveig; Jabeen, Shakila; Egeland, Eivind Valen; Nord, Silje; Pandya, Abhilash D.; Haugen, Mads Haugland; Kristensen, Vessela N.; Børresen-Dale, Anne-Lise; Engebråten, Olav & Mælandsmo, Gunhild Mari (2018). Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4. Molecular Oncology.  ISSN 1574-7891.  12(9), s 1540- 1558 . doi: 10.1002/1878-0261.12319 Full text in Research Archive.
  • Seip, Kotryna; Jørgensen, Kjetil; Haselager, Marco Vincent; Albrecht, Marco; Haugen, Mads Haugland; Egeland, Eivind Valen; Lucarelli, Philippe; Engebråten, Olav; Sauter, Thomas; Mælandsmo, Gunhild Mari & Prasmickaite, Lina (2018). Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment. Cancer Letters.  ISSN 0304-3835.  439, s 1- 13 . doi: 10.1016/j.canlet.2018.09.023 Full text in Research Archive.
  • Euceda, Leslie R.; Haukaas, Tonje Husby; Giskeødegård, Guro F.; Vettukattil, Muhammad Riyas; Engel, Jasper; Silwal-Pandit, Laxmi; Lundgren, Steinar; Borgen, Elin; Garred, Øystein; Postma, Geert; Buydens, Lutgarde M.C.; Børresen-Dale, Anne-Lise; Engebråten, Olav & Bathen, Tone Frost (2017). Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy. Metabolomics.  ISSN 1573-3882.  13:37, s 1- 14 . doi: 10.1007/s11306-017-1168-0 Full text in Research Archive.
  • Kristian, Alexandr; Holtedahl, Jon Erik; Torheim, Turid K Gjerstad; Futsæther, Cecilia Marie; Hernes, Eivor; Engebråten, Olav; Mælandsmo, Gunhild & Malinen, Eirik (2017). Dynamic 2-Deoxy-2-[<sup>18</sup>F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts. Molecular Imaging and Biology.  ISSN 1536-1632.  19(2), s 271- 279 . doi: 10.1007/s11307-016-0998-x
  • Reinertsen, Kristin Valborg; Engebråten, Olav; Loge, Jon Håvard; Småstuen, Milada Cvancarova; Naume, Bjørn; Wist, Erik; Edvardsen, Hege; Wille, Elisabeth; Bjøro, Trine & Kiserud, Cecilie E. (2017). Fatigue During and After Breast Cancer Therapy—A Prospective Study. Journal of Pain and Symptom Management.  ISSN 0885-3924.  53(3), s 551- 560 . doi: 10.1016/j.jpainsymman.2016.09.011 Full text in Research Archive.
  • Saldova, Radka; Haakensen, Vilde Drageset; Rødland, Einar Andreas; Walsh, Ian; Stöckmann, Henning; Engebråten, Olav; Børresen-Dale, Anne-Lise & Rudd, Pauline M. (2017). Serum N-glycome alterations in breast cancer during multimodal treatment and follow-up. Molecular Oncology.  ISSN 1574-7891.  11(10), s 1361- 1379 . doi: 10.1002/1878-0261.12105 Show summary
  • Silwal-Pandit, Laxmi; Nord, Silje; Gythfeldt, Hedda; Møller, Elen Kristine; Fleischer, Thomas; Rødland, Einar Andreas; Krohn, Marit; Borgen, Elin; Garred, Øystein; Olsen, Tone; Vu, Phuong Ngoc Thi; Skjerven, Helle; Fangberget, Anne; Holmen, Marit Muri; Schlichting, Ellen; Wille, Elisabeth; Stokke, Mette Norberg; Vollan, Hans Kristian Moen; Kristensen, Vessela N.; Langerød, Anita; Lundgren, Steinar; Wist, Erik; Naume, Bjørn; Lingjærde, Ole Christian; Børresen-Dale, Anne-Lise & Engebråten, Olav (2017). The longitudinal transcriptional response to neoadjuvant chemotherapy with and without bevacizumab in breast cancer. Clinical Cancer Research.  ISSN 1078-0432.  23(16), s 4662- 4670 . doi: 10.1158/1078-0432.CCR-17-0160 Full text in Research Archive.
  • Øverbye, Anders; Holsæter, Ann Mari; Fusser, Markus; Skalko-Basnet, Natasa; Iversen, Tore Geir; Torgersen, Maria Lyngaas; Sønstevold, Tonje; Engebråten, Olav; Flatmark, Kjersti; Mælandsmo, Gunhild; Skotland, Tore & Sandvig, Kirsten (2017). Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide. OncoTarget.  ISSN 1949-2553.  8(44), s 76921- 76934 . doi: 10.18632/oncotarget.20217 Full text in Research Archive.
  • Easton, Douglas F; Lesueur, Fabienne; Decker, Brennan; Michailidou, Kyriaki; Li, Jun; Allen, Jamie; Luccarini, Craig; Pooley, Karen A.; Shah, Mitul; Bolla, Manjeet K.; Wang, Qin; Dennis, Joe; Ahmad, Jamil; Thompson, Ella R.; Damiola, Francesca; Pertesi, Maroulio; Voegele, Catherine; Mebirouk, Noura; Robinot, Nivonirina; Durand, Geoffroy; Forey, Nathalie; Luben, Robert N.; Ahmed, Shahana; Aittomäki, Kristiina; Anton-Culver, Hoda; Arndt, Volker; Baynes, Caroline; Beckman, Matthias W.; Benitez, Javier; Van Den Berg, David; Blot, William J.; Bogdanova, Natalia V; Bojesen, Stig E.; Brenner, Hermann; Chang-Claude, Jenny; Chia, Kee Seng; Choi, Ji-Yeob; Conroy, Don M.; Cox, Angela; Cross, Simon S.; Czene, Kamila; Darabi, Hatef; Devilee, Peter; Eriksson, Mikael; Fasching, Peter A.; Figueroa, Jonine; Flyger, Henrik; Fostira, Florentia; García-Closas, Montserrat; Giles, Graham G.; Glendon, Gord; Gonzalez-Neira, Anna; Guenel, Pascal; Haiman, Christopher A.; Hall, Per; Hart, Steven N; Hartman, Mikael; Hooning, Maartje J.; Hsiung, Chia-Ni; Ito, Hidemi; Jakubowska, Anna; James, Paul A.; John, Esther M.; Johnson, Nichola; Jones, Michael; Kabisch, Maria; Kang, Daehee; Kosma, Veli-Matti; Kristensen, Vessela N.; Lambrechts, Diether; Li, Na; Myöhänen, Eija; Kemiläinen, Helena; Lindblom, Annika; Long, Jirong; Lophatananon, Artitaya; Lubinski, Jan; Mannermaa, Arto; Manoukian, Siranoush; Margolin, Sara; Matsuo, Keitaro; Meindl, Alfons; Mitchell, Gillian; Muir, Kenneth; Nevelsteen, Ines; Van Den Ouweland, Ans; Peterlongo, Paolo; Phuah, Sze Yee; Pylkäs, Katri; Rowley, Simone M; Sangrajrang, Suleeporn; Schmutzler, Rita K; Shen, Chen-Yang; Shu, Xiao-Ou; Southey, Melissa C; Surowy, Harald; Swerdlow, Anthony; Teo, Soo H; Tollenaar, Rob AEM; Tomlinson, Ian; Torres, Diana; Truong, Therese; Vachon, Celine; Verhoef, Senno; Wong-Brown, Michelle; Zheng, Wei; Zheng, Ying; Nevanlinna, Heli; Scott, Rodney J.; Andrulis, Irene L.; Wu, Anna H.; Hopper, John L.; Couch, Fergus J.; Winqvist, Robert; Burwinkel, Barbara; Sawyer, Elinor J.; Schmidt, Marjanka K.; Rudolph, Anja; Dörk, Thilo; Brauch, Hiltrud; Hamann, Ute; Neuhausen, Susan L.; Milne, Roger L.; Fletcher, Olivia; Pharoah, Paul D.P.; Campbell, Ian G.; Dunning, Alison M.; Le Calvez-Kelm, Florence; Goldgar, David E.; Tavtigian, Sean V.; Chenevix-Trench, Georgia; Kleivi, Kristine; Sauer, Torill; Riis, Margit; Grenaker, Grethe Irene; Bukholm, Ida Rashida Khan; Kiserud, Cecilie E.; Nord, Silje; Lønning, Per Eystein; Helland, Åslaug; Reinertsen, Kristin Valborg; Naume, Bjørn; Haakensen, Vilde Drageset; Ottestad, Lars; Kåresen, Rolf; Holmen, Marit Muri; Engebråten, Olav; Langerød, Anita & Schlichting, Ellen (2016). No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: Implications for gene panel testing. Journal of Medical Genetics.  ISSN 0022-2593.  53(5), s 298- 309 . doi: 10.1136/jmedgenet-2015-103529
  • Kim, Eugene; Tunset, Hanna Maja; Cebulla, Jana; Vettukattil, Muhammad Riyas; Helgesen, Heidi; Feuerherm, Astrid Jullumstrø; Engebråten, Olav; Mælandsmo, Gunhild; Johansen, Berit & Moestue, Siver Andreas (2016). Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model. BMC Cancer.  ISSN 1471-2407.  16:191 . doi: 10.1186/s12885-016-2225-1 Full text in Research Archive.
  • Sas-Chen, Aldema; Aure, Miriam Ragle; Leibovich, Limor; Carvalho, Silvia; Enuka, Yehoshua; Körner, Cindy; Polycarpou-Schwarz, Maria; Lavi, Sara; Nevo, Nava; Kuznetsov, Yuri; Yuan, Justin; Azuaje, Francisco; Ulitsky, Igor; Diederichs, Sven; Wiemann, Stefan; Yakhini, Zohar; Kristensen, Vessela N.; Børresen-Dale, Anne-Lise; Yarden, Yosef; Sauer, Torill; Geisler, Jürgen; Hofvind, Solveig; Bathen, Tone Frost; Borgen, Elin; Engebråten, Olav; Fodstad, Øystein; Garred, Øystein; Geitvik, Gry; Kåresen, Rolf; Naume, Bjørn; Mælandsmo, Gunhild; Russnes, Hege Elisabeth Giercksky; Schlichting, Ellen; Sørlie, Therese; Lingjærde, Ole Christian; Sahlberg, Kristine Kleivi; Skjerven, Helle & Fritzman, Britt (2016). LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. EMBO Molecular Medicine.  ISSN 1757-4676.  8(9), s 1052- 1064 . doi: 10.15252/emmm.201606198 Full text in Research Archive.
  • Andersson, Yvonne; Engebråten, Olav; Juell, Siri; Aamdal, Steinar; Brunsvig, Paal Fr.; Fodstad, Øystein & Dueland, Svein (2015). Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin. British Journal of Cancer.  ISSN 0007-0920.  113(11), s 1548- 1555 . doi: 10.1038/bjc.2015.380
  • Bagheri Fam, Shahla; Skjeldal, Frode Miltzow; Griffiths, Gareth Wyn; Mælandsmo, Gunhild; Engebråten, Olav; Nyström, Bo; Hasirci, Vasif & Hasirci, Nesrin (2015). pH-Responsive Nano Carriers for Doxorubicin Delivery. Pharmaceutical Research.  ISSN 0724-8741.  32(4), s 1249- 1263 . doi: 10.1007/s11095-014-1530-0
  • Esmaeili, Morteza; Moestue, Siver Andreas; Hamans, Bob C.; Veltien, Andor; Kristian, Alexandr; Engebråten, Olav; Mælandsmo, Gunhild; Gribbestad, Ingrid S; Bathen, Tone & Heerschap, Arend (2015). In vivo 31P MRSI for metabolic profiling of human breast cancer xenografts. Journal of Magnetic Resonance Imaging.  ISSN 1053-1807.  41(3), s 601- 609 . doi: 10.1002/jmri.24588 Full text in Research Archive.
  • Pfister, Neil T.; Fomin, Vitalay; Regunath, Kausik; Zhou, Jeffrey Y.; Zhou, Wen; Silwal-Pandit, Laxmi; Freed-Pastor, William A.; Laptenko, Oleg; Neo, Suat Peng; Bargonetti, Jill; Hoque, Mainul; Tian, Bin; Gunaratne, Jayantha; Engebråten, Olav; Manley, James L.; Børresen-Dale, Anne-Lise; Neilsen, Paul M. & Prives, Carol (2015). Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells. Genes & Development.  ISSN 0890-9369.  29(12), s 1298- 1315 . doi: 10.1101/gad.263202.115
  • Esmaeili, Morteza; Bathen, Tone Frost; Engebråten, Olav; Mælandsmo, Gunhild; Gribbestad, Ingrid S & Moestue, Siver Andreas (2014). Quantitative 31P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts. Magnetic Resonance in Medicine.  ISSN 0740-3194.  71(6), s 1973- 1981 . doi: 10.1002/mrm.24869 Full text in Research Archive.
  • Grinde, Maria Tunset; Skrbo, Nirma; Moestue, Siver Andreas; Rødland, Einar Andreas; Borgan, Eldrid; Kristian, Alexandr; Sitter, Beathe; Bathen, Tone; Børresen-Dale, Anne-Lise; Mælandsmo, Gunhild; Engebråten, Olav; Sørlie, Therese; Marangoni, Elisabetta & Gribbestad, Ingrid S (2014). Interplay of choline metabolites and genes in patient-derived breast cancer xenografts. Breast Cancer Research.  ISSN 1465-5411.  16(1) . doi: 10.1186/bcr3597 Full text in Research Archive.
  • Kristian, Alexandr; Riss, Patrick; Qu, Hong; Milde, Mona; Schoultz, Bent Wilhelm; Engebråten, Olav; Mælandsmo, Gunhild & Malinen, Eirik (2014). Positron emission tomography and pharmacokinetics of 2-[18F]-fluoroethyl choline for metabolic studies in breast cancer xenografts. Acta Oncologica.  ISSN 0284-186X.  53(8), s 1086- 1092 . doi: 10.3109/0284186X.2014.934398
  • Lindholm, Evita Maria; Krohn, Marit; Iadevaia, Sergio; Kristian, Alexandr; Mills, Gordon B.; Mælandsmo, Gunhild & Engebråten, Olav (2014). Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations. Clinical Cancer Research.  ISSN 1078-0432.  20(2), s 404- 412 . doi: 10.1158/1078-0432.CCR-13-1865
  • Nilsen, Line; Fangberget, Anne; Geier, Oliver; Engebråten, Olav; Borgen, Elin; Olsen, Dag Rune & Seierstad, Therese (2014). Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis. Journal of Magnetic Resonance Imaging.  ISSN 1053-1807.  40(6), s 1382- 1391 . doi: 10.1002/jmri.24502
  • Skrbo, Nirma; Hjortland, Geir Olav; Kristian, Alexandr; Holm, Ruth; Nordgard, Silje H.; Prasmickaite, Lina; Engebråten, Olav; Mælandsmo, Gunhild; Sørlie, Therese & Andersen, Kristin (2014). Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft. PLOS ONE.  ISSN 1932-6203.  9(11) . doi: 10.1371/journal.pone.0113278 Full text in Research Archive.
  • Moestue, Siver Andreas; Dam, Cornelia Gerarda; Gorad, Saurabh Sayajirao; Kristian, Alexandr; Bofin, Anna M.; Mælandsmo, Gunhild; Engebråten, Olav; Gribbestad, Ingrid S & Bjørkøy, Geir (2013). Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Research.  ISSN 1465-5411.  15(1:R16) . doi: 10.1186/bcr3391 Full text in Research Archive.
  • Borgan, Eldrid; Lindholm, Evita Maria; Moestue, Siver Andreas; Mælandsmo, Gunhild; Lingjærde, Ole Christian; Gribbestad, Ingrid S; Børresen-Dale, Anne-Lise; Engebråten, Olav & Sørlie, Therese (2013). Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts. Molecular Oncology.  ISSN 1574-7891.  7(1), s 130- 142 . doi: 10.1016/j.molonc.2012.10.005 Full text in Research Archive.
  • Engebråten, Olav; Vollan, Hans Kristian Moen & Børresen-Dale, Anne-Lise (2013). Triple-negative breast cancer and the need for new therapeutic targets. American Journal of Pathology.  ISSN 0002-9440.  183(4), s 1064- 1074 . doi: 10.1016/j.ajpath.2013.05.033
  • Kristian, Alexandr; Nilsen, Line; Røe, Kathrine; Revheim, Mona Elisabeth; Engebråten, Olav; Mælandsmo, Gunhild; Holm, Ruth; Malinen, Eirik & Seierstad, Therese (2013). Dynamic 18F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts. Nuclear medicine and molecular imaging.  ISSN 1869-3474.  47, s 173- 180 . doi: 10.1007/s13139-013-0211-y
  • Kristian, Alexandr; Revheim, Mona Elisabeth; Qu, Hong; Mælandsmo, Gunhild; Engebråten, Olav; Seierstad, Therese & Malinen, Eirik (2013). Dynamic F-18-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts. Acta Oncologica.  ISSN 0284-186X.  52(7), s 1566- 1572 . doi: 10.3109/0284186X.2013.813634
  • Moestue, Siver Andreas; Dam, Cornelia Gerarda; Gorad, Saurabh Sayajirao; Kristian, Alexandr; Bofin, Anna M.; Mælandsmo, Gunhild; Engebråten, Olav; Gribbestad, Ingrid S & Bjørkøy, Geir (2013). Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Research.  ISSN 1465-5411.  15(1)
  • Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria; Bofin, Anna M.; Engebråten, Olav; Mælandsmo, Gunhild; Akslen, Lars A. & Gribbestad, Ingrid S (2013). Low-molecular contrast agent DCE-MRI and DW-MRI in early assessment of bevacizumab treatment in breast cancer xenografts. Journal of Magnetic Resonance Imaging.  ISSN 1053-1807.  38(5), s 1043- 1053 . doi: 10.1002/jmri.24079
  • Huuse, Else Marie; Moestue, Siver Andreas; Lindholm, Evita Maria; Bathen, Tone Frost; Nalwoga, Hawa; Krüger, Kristi; Bofin, Anna M.; Mælandsmo, Gunhild; Akslen, Lars A.; Engebråten, Olav & Gribbestad, Ingrid S (2012). In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. Journal of Magnetic Resonance Imaging.  ISSN 1053-1807.  35(5), s 1098- 1107 . doi: 10.1002/jmri.23507
  • Engebråten, Olav; Edvardsen, Hege; Løkkevik, Erik; Naume, Bjørn; Kristensen, Vessela N.; Ottestad, Lars & Natarajan, Vasanti (2012). Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial. ISRN Oncology.  ISSN 2090-5661. . doi: 10.5402/2012/176789
  • Engesæter, Birgit Øvstebø; Engebråten, Olav; Flørenes, Vivi Ann & Mælandsmo, Gunhild (2012). Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma. PLOS ONE.  ISSN 1932-6203.  7(9) . doi: 10.1371/journal.pone.0045492 Full text in Research Archive.
  • Lindholm, Evita Maria; Kristian, Alexandr; Nalwoga, Hawa; Kruger, Kristi; Nygård, Ståle; Akslen, Lars A.; Mælandsmo, Gunhild & Engebråten, Olav (2012). Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts. Molecular Oncology.  ISSN 1574-7891.  6(4), s 418- 427 . doi: 10.1016/j.molonc.2012.03.006
  • Engesæter, Birgit Øvstebø; Sathermugathevan, Menaka; Hellesnes, Tina; Engebråten, Olav; Holm, Ruth; Flørenes, Vivi Ann & Mælandsmo, Gunhild (2011). Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells. Cancer Biology & Therapy.  ISSN 1538-4047.  12(1), s 47- 58 . doi: 10.4161/cbt.12.1.15714
  • Fangberget, Anne; Nilsen, Line; Hole, Knut Håkon; Holmen, Marit Muri; Engebråten, Olav; Naume, Bjørn; Smith, Hans-Jørgen; Olsen, Dag Rune & Seierstad, Therese (2011). Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. European Radiology.  ISSN 0938-7994.  21(6), s 1188- 1199 . doi: 10.1007/s00330-010-2020-3
  • Grinde, Maria Tunset; Moestue, Siver Andreas; Borgan, Eldrid; Risa, Øystein; Engebråten, Olav & Gribbestad, Ingrid S (2011). 13C High-resolution-magic angle spinning MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns. NMR in Biomedicine.  ISSN 0952-3480.  24(10), s 1243- 1252 . doi: 10.1002/nbm.1683
  • Moestue, Siver Andreas; Engebråten, Olav & Gribbestad, Ingrid S (2011). Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy. Molecular Oncology.  ISSN 1574-7891.  5(3), s 224- 241 . doi: 10.1016/j.molonc.2011.04.001 Full text in Research Archive.
  • Moestue, Siver Andreas; Borgan, Eldrid; Huuse, Else Marie; Lindholm, Evita Maria; Sitter, Beathe; Børresen-Dale, Anne-Lise; Engebråten, Olav; Mælandsmo, Gunhild & Gribbestad, Ingrid S (2010). Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer.  ISSN 1471-2407.  10 . doi: 10.1186/1471-2407-10-433
  • Andersson, Y; Engebråten, Olav & Fodstad, Øystein (2009). Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo. British Journal of Cancer.  ISSN 0007-0920.  101(8), s 1307- 1315 . doi: 10.1038/sj.bjc.6605312
  • Bergamaschi, Anna; Hjortland, Geir Olav; Triulzi, T; Sørlie, Therese; Johnsen, Hilde; Ree, Anne Hansen; Russnes, Hege G; Tronnes, Sigurd; Mælandsmo, Gunhild M; Fodstad, Øystein; Børresen-Dale, Anne-Lise & Engebråten, Olav (2009). Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models. Molecular Oncology.  ISSN 1574-7891.  3(5-6), s 469- 482 . doi: 10.1016/j.molonc.2009.07.003
  • Christoffersen, Thoralf; Gjertsen, Bjørn Tore; Engebråten, Olav & Guren, Tormod K. (2009). Signalhemmere, I:  Medikamentell kreftbehandling.  Farmakologisk institutt, Det medisinske fakultet, Universitetet i Oslo.  ISBN 978-829923312-5.  Kapittel 17.  s 226 - 249
  • Engebråten, Olav; Trikha, M; Juell, S; Garman-Vik, S & Fodstad, Øystein (2009). Inhibition of In Vivo Tumour Growth by the Blocking of Host alpha(v)beta(3) and alpha IIb beta(3) Integrins. Anticancer Research.  ISSN 0250-7005.  29(1), s 131- 137
  • Lillehammer, T; Engesaeter, BO; Prasmickaite, L; Maelandsmo, GM; Fodstad, Øystein & Engebråten, Olav (2007). Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines. Journal of Gene Medicine.  ISSN 1099-498X.  9, s 440- 451 . doi: 10.1002/jgm.1036
  • Engesaeter, BO; Tveito, S; Bonsted, A; Engebråten, Olav; Berg, K; Maelandsmo, GM & Mælandsmo, Gunhild M (2006). Photochemical treatment with endosomally localized photosensitizers enhances the number of adenoviruses in the nucleus. Journal of Gene Medicine.  ISSN 1099-498X.  8, s 707- 718
  • Engesæter, Birgit Øvstebø; Bonsted, Anette; Lillehammer, Trine; Engebråten, Olav; Berg, Kristian & Mælandsmo, Gunhild M (2006). Photochemically mediated delivery of AdhCMV-TRAIL augments the TRAIL-induced apoptosis in colorectal cancer cell lines. Cancer Biology & Therapy.  ISSN 1538-4047.  5(11), s 1511- 1520
  • Madsen, S; Friesen, S.; Hjortland, Geir Olav; Engebråten, Olav; Qian, Peng & Hirschberg, Henry (2004). Protoporphyrin IX distribution in rat brain tumor following administration of 5-aminolevulinic acid or its hexylester. Proceedings of SPIE, the International Society for Optical Engineering.  ISSN 0277-786X.  5312, s 396- 404
  • Hjortland, Geir Olav; Garman-Vik, Solveig Suzanne; Juell, Siri; Olsen, Øyvind Edon; Hirschberg, Henry; Fodstad, Øystein & Engebråten, Olav (2004). Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme. Journal of Neurosurgery.  ISSN 0022-3085.  100, s 320- 327
  • Hjortland, Geir Olav; Lillehammer, Trine; Somme, Stig; Wang, Junbai; Halvorsen, Thomas; Juell, Siri; Hirschberg, Henry; Fodstad, Øystein & Engebråten, Olav (2004). Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells. Experimental Cell Research.  ISSN 0014-4827.  294, s 130- 139 . doi: 10.1016/j.yexcr.10.013
  • Hjortland, Geir Olav; Bjørnland, Kristin; Pettersen, Solveig; Garman-Vik, S.S.; Emilsen, Elisabeth; Nesland, Jahn M; Fodstad, Øystein & Engebråten, Olav (2003). Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1. Clinical and Experimental Metastasis.  ISSN 0262-0898.  20, s 301- 309
  • Friesen, S.; Hjortland, Geir Olav; Hirschberg, Henry; Engebråten, Olav; Madsen, S.J.; Nesland, Jahn M & Peng, Qian (2002). 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors. International Journal of Oncology.  ISSN 1019-6439.  21, s 577- 582
  • Engebråten, Olav; Sivam, G.; Juell, Siri & Fodstad, Øystein (2000). Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats. International Journal of Cancer.  ISSN 0020-7136.  s 970- 976
  • Suzuki, T.; Anderegg, B.; Ohkawa, T.; Ire, A.; Engebråten, Olav; Halks-Miler, M.; Holm, P. S.; Curiel, D.T.; Kashani-Sabet, M. & Scanlon, K.J. (2000). Adenovirus-meditated ribozyme targeting of HER-2/neu inhibits in vivi growth of breast cancer cells. Gene Therapy.  ISSN 0969-7128.  s 241- 248
  • Visted, T.; Thorsen, F.; Read, T.A.; Ulvestad, E.; Engebråten, Olav; Sorensen, D.R.; Yla-Herttuala, S.; Tyynela, K.; Ruckligde, G.; Edvardsen, Kåre; Bjerkvig, R.; Thorsen, Jim & Johansen, M. Lund (2000). lacZ-neoR transfected glioma cells in syngenetic rats: growth pattern and characterization of the most immune response against cells transplanted inside and outside the CNS. International Journal of Cancer.  ISSN 0020-7136.  s 228- 235
  • Engebråten, Olav & Fodstad, Øystein (1999). Site specific experimental metastasis patterns of two human breast cancer cell lines in nude rats. International Journal of Cancer.  ISSN 0020-7136.  82, s 219- 225
  • Ree, Anne Hansen; Tvermyr, Marianne; Engebråten, Olav; Rooman, M.; Rosok, O.; Hovig, Eivind; Meza-Zepeda, Leonardo A.; Bruland, Øyvind & Fodstad, Øystein (1999). Expression of a novel factor in human breast cancer cells with metastatic potential. Cancer Research.  ISSN 0008-5472.  s 4675- 4680
  • Ree, Anne Hansen; Tvermyr, Marianne; Engebråten, Olav; Rooman, M.; Røsok, Øystein; Hovig, Eivind; Meza-Zepeda, Leonardo A.; Bruland, Øyvind & Fodstad, Øystein (1999). Expression of a noval factor in human breast cancer cells with metastatic potential. International Journal of Molecular Medicine.  ISSN 1107-3756.  3, s 381- 384
  • Ree, Anne Hansen; Tvermyr, Marianne; Engebråten, Olav; Rooman, M.; Røsok, Øystein; Hovig, Eivind; Meza-Zepeda, Leonardo A.; Bruland, Øyvind & Fodstad, Øystein (1999). Expression of a novel factor in human breast cancer cells with metastatic potential. Cancer Research.  ISSN 0008-5472.  59, s 4675- 4680
  • Wyller, Torgeir Bruun & Engebråten, Olav (1998). Bruk av antipsykotiske legemidler i en langtidsinstitusjon. Erfatinger med innføring av kliniske retningslinjer. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  118, s 4247- 4251
  • Mælandsmo, Gunhild Mari; Flørenes, Vivi Ann; Hovig, Eivind; Øyjord, T.; Engebråten, Olav; Holm, Ruth; Børresen-Dale, Anne-Lise & Fodstad, Øystein (1996). Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumourigenesis of sporadic malignant melanomas. British Journal of Cancer.  ISSN 0007-0920.  73, s 909- 916
  • Mælandsmo, Gunhild Mari; Hovig, Eivind; Skrede, Martina; Engebråten, Olav; Flørenes, Vivi Ann; Myklebost, Ola; Grigorian, M.S.; Lukanidin, E. & Fodstad, Øystein (1996). Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts-1) ribozyme. Cancer Research.  ISSN 0008-5472.  5490, s 5490- 5498

View all works in Cristin

  • Christoffersen, Thoralf; Helland, Åslaug; Engebråten, Olav; Straume, Oddbjørn & Guren, Tormod Kyrre (2016). Signalhemmere, I: Olav Dahl; Gustav Lehne & Thoralf Christoffersen (red.),  Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016.  Avdeling for farmakologi, Universitetet i Oslo.  ISBN 978-82-992331-4-9.  Kapittel 17.  s 282 - 328
  • Kim, Eugene; Kim, Jana; Feuerherm, Astrid Jullumstrø; Engebråten, Olav; Mælandsmo, Gunhild; Johansen, Berit & Moestue, Siver Andreas (2016). Different anti-angiogenic drugs have different effects on the relationship between vascular structure and function in a patient-derived breast cancer model.
  • Skrbo, Nirma; Kirik, U.; Kristian, Alexandr; Cifani, P.; Antberg, L.; Moestue, Siver Andreas; Engebråten, Olav; Mælandsmo, Gunhild; Andersen, Kristin; James, Peter & Sørlie, Therese (2016). Protein expression analysis of intratumor heterogeneity in a luminal-like breast cancer xenograft..
  • Euceda, Leslie R.; Haukaas, Tonje Husby; Giskeødegård, Guro F.; Vettukattil, Muhammad Riyas; Engel, Jasper; Postma, Geert; Buydens, Lutgarde M.C.; Børresen-Dale, Anne-Lise; Engebråten, Olav & Bathen, Tone Frost (2015). Evaluation of neoadjuvant chemotherapy in breast cancer using MR metabolomics.
  • Euceda, Leslie R.; Haukaas, Tonje Husby; Giskeødegård, Guro F.; Vettukattil, Muhammad Riyas; Postma, Geert; Engel, Jasper; Buydens, Lutgarde M.C.; Børresen-Dale, Anne-Lise; Engebråten, Olav & Bathen, Tone Frost (2015). Evaluation of neoadjuvant chemotherapy in breast cancer using MR metabolomics.
  • Kim, Eugene; Feuerherm, Astrid Jullumstrø; Johansen, Berit; Engebråten, Olav; Mælandsmo, Gunhild; Bathen, Tone Frost & Moestue, Siver Andreas (2015). cPLA2 Inhibition Affects the Relationship Between Vascular Function and Structure in a Patient-Derived Breast Cancer Model: A Correlation Study of DCE-MRI Vs. Micro-CT.
  • Kristian, Alexandr; Revheim, Mona Elisabeth; Mælandsmo, Gunhild; Engebråten, Olav & Malinen, Eirik (2014). Variation in dynamic 18FFDG PET parameters in breast cancer PDX and correlation to treatment outcome. Radiotherapy and Oncology.  ISSN 0167-8140.  111, s 387- 387
  • Kristian, Alexandr; Revheim, Mona Elisabeth; Qu, Hong; Mælandsmo, Gunhild; Engebråten, Olav & Malinen, Eirik (2014). Dynamic 18F-FDG PET parameters variation in patient-derived breast cancer xenograft and correlation with outcome following treatment with cytotoxic agents. Cancer Research.  ISSN 0008-5472.  74 . doi: 10.1158/1538-7445.AM2014-2053
  • Kristian, Alexandr; Riss, Patrick; Qu, Hong; Milde, Mona; Schoultz, Bent Wilhelm; Engebråten, Olav; Mælandsmo, Gunhild & Malinen, Eirik (2014). Pharmacokinetic modeling of dynamic 18F‐Choline PET reflects choline metabolism in breast carcinoma xenografts.
  • Moestue, Siver Andreas; Grinde, Maria Tunset; Marangoni, Elisabetta; Skrbo, Nirma; Rødland, Einar Andreas; Borgan, Eldrid; Kristian, Alexandr; Gorad, Saurabh Sayajirao; Sitter, Beathe; Bathen, Tone Frost; Børresen-Dale, Anne-Lise; Mælandsmo, Gunhild; Engebråten, Olav; Gribbestad, Ingrid S & Sørlie, Therese (2013). Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
  • Engebråten, Olav; Vaske, Charles J.; Krohn, Marit; Silwal-Pandit, Laxmi; Vollan, Hans Kristian Moen; Møller, Elen Kristine; Nord, Silje; Fleischer, Thomas; Borgen, Elin; Edvardsen, Hege; Garred, Øystein; Fangberget, Anne; Holmen, Marit Muri; Schlichting, Ellen; Skjerven, Helle; Lundgren, Steinar; Wist, Erik; Naume, Bjørn; Børresen-Dale, Anne-Lise & Kristensen, Vessela N. (2013). Molecular response in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva - A randomized study.
  • Esmaeili, Morteza; Bathen, Tone Frost; Engebråten, Olav; Mælandsmo, Gunhild; Gribbestad, Ingrid S & Moestue, Siver Andreas (2013). Quantitative 31P Magnetic Resonance Spectroscopy Stratifies Treatment Response to a PI3K/mTOR Inhibitor in Two Distinct Breast Cancer Xenografts.
  • Esmaeili, Morteza; Bathen, Tone Frost; Engebråten, Olav; Mælandsmo, Gunhild; Gribbestad, Ingrid S & Moestue, Siver Andreas (2013). Quantitative 31P Magnetic Resonance Spectroscopy Stratifies Treatment Response to a PI3K/mTOR Inhibitor in Two Distinct Breast Cancer Xenografts.
  • Mathiesen, Randi R.; Borgen, Elin; Sætersdal, Anna Barbro; Fangberget, Anne; Schirmer, Cecilie; Stav, I; Fagerland, Morten; Wist, Erik; Engebråten, Olav & Naume, Bjørn (2013). Detection and monitoring of circulating endothelial cells, circulating tumor cells and disseminated tumor cells during neoadjuvant breast cancer treatment including bevacizumab.
  • Moestue, Siver Andreas; Grinde, Maria Tunset; Marangoni, Eilsabetta; Sørlie, Therese; Engebråten, Olav; Mælandsmo, Gunhild; Johansen, Berit & Bathen, Tone Frost (2013). Cytosolic phospholipase A2 (cPLA2) as a therapeutic target in basal-like breast cancer.
  • Møller, Elen Kristine; Vollan, Hans Kristian Moen; Nord, Silje; von der Lippe Gythfeldt, H; Edvardsen, Hege; Silwal-Pandit, Laxmi; Krohn, Marit; Fleischer, Thomas; Schlichting, Ellen; Borgen, Elin; Garred, Øystein; Fangberget, Anne; Holmen, Marit Muri; Skjerven, Helle; Lundgren, Steinar; Wist, Erik; Naume, Bjørn; Børresen-Dale, Anne-Lise; Kristensen, Vessela N. & Engebråten, Olav (2013). A time course study of genomic instability in breast cancer patients receiving neoadjuvant chemotherapy with or without bevacizumab.
  • Moestue, Siver Andreas; Flatabø, Silje; Huuse, Else Marie; Lindholm, Evita Maria; Engebråten, Olav; Akslen, Lars A.; Mælandsmo, Gunhild & Gribbestad, Ingrid S (2012). Metabolic responses to VEGF inhibition in patient-derived breast cancer xenografts.
  • Huuse, Else Marie; Moestue, Siver Andreas; Bathen, Tone Frost; Bofin, Anna M.; Mælandsmo, Gunhild; Akslen, Lars A.; Engebråten, Olav & Gribbestad, Ingrid S (2011). In vivo Dynamic Contrast Enhanced MRI & Histopathological Assessment of Tumor Angiogenesis in Luminal-like and Basal-like Breast Cancer Xenografts.
  • Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria; Akslen, Lars A.; Engebråten, Olav; Mælandsmo, Gunhild & Gribbestad, Ingrid S (2011). Early vascular response to bevacizumab treatment measured by DCE-MRI in breast cancer xenografts.
  • Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria; Engebråten, Olav; Akslen, Lars A.; Mælandsmo, Gunhild & Gribbestad, Ingrid S (2011). DCE-MRI for early therapy monitoring of anti-angiogenic therapy.
  • Grinde, Maria Tunset; Moestue, Siver Andreas; Borgan, Eldrid; Risa, Øystein; Engebraaten, Olav & Gribbestad, Ingrid S (2010). 13C HR-MAS MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns.
  • Grinde, Maria Tunset; Moestue, Siver Andreas; Eldrid, Borgan; Risa, Øystein; Engebraaten, Olav & Gribbestad, Ingrid S (2010). 13C HR MAS MRS reveals differences in the glucose metabolism between two breast cancer xenograft models with different gene expression pattern.
  • Grinde, Maria Tunset; Moestue, Siver Andreas; Eldrid, Borgan; Risa, Øystein; Engebraaten, Olav & Gribbestad, Ingrid S (2010). 13C HR-MAS MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns.
  • Huuse, Else Marie; Moestue, Siver Andreas; Lindholm, Evita; Bathen, Tone Frost; Nalvoga, Hawa; Bofin, Anna M.; Mælandsmo, Gunhild; Akslen, Lars A.; Engebraaten, Olav & Gribbestad, Ingrid S (2010). In vivo magnetic resonance imaging and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.
  • Prasmickaite, Lina; Skrbo, Nirma; Høifødt, Hanne Kleppe; Suo, Zhenhe; Engebråten, Olav; Gullestad, Hans petter; Aamdal, Steinar; Fodstad, Øystein & Mælandsmo, Gunhild M (2010). Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells. Pigment Cell & Melanoma Research.  ISSN 1755-1471.  23(3), s 449- 451 . doi: 10.1111/j.1755-148X.2010.00690.x
  • Lillehammer, Trine; Engebråten, Olav & Mælandsmo, Gunhild M (2007). Adenovirus-mediated gene transfer to melanoma and glioma cells. A study of transcriptional targeting and candidate therapeutic genes.
  • Engebråten, Olav; Hjortland, Geir Olav; Juell, Siri; Hirschberg, Henry & Fodstad, Øystein (2002). Intratumoral immuntoxin treatment of human malignant brain tumors in immunodeficient animals. International Journal of Cancer.  ISSN 0020-7136.  97, s 846- 852
  • Ree, Anne Hansen; Engebråten, Olav; Hovig, Eivind & Fodstad, Øystein (2002). Differential display analysis of carcinoma cells enriched by immunomagnetic target cell selection:gene expression profiles in bone marrow target cells. International Journal of Cancer.  ISSN 0020-7136.  97, s 28- 33

View all works in Cristin

Published Apr. 13, 2011 2:54 PM - Last modified Nov. 5, 2015 1:34 PM